Literature DB >> 1565817

Changes in spirometry during consecutive admissions for infective pulmonary exacerbations in adolescent and adult cystic fibrosis.

G E Packe1, M E Hodson.   

Abstract

Changes in spirometry during consecutive admissions for treatment of pulmonary infective exacerbations were studied in 45 patients (24 males, 21 females) with cystic fibrosis (CF) who had required five or more such admissions. Over the overall study period there was a mean (SD) decline in FEV1 of -112.1 (188.0) ml yr-1 (P less than 0.001) and in FVC of -47.9 (82.4) ml yr-1 (P less than 0.001). FEV1 and FVC increased during each admission with treatment; however, the magnitude of this change became less over consecutive admissions by a mean value of -33.3 ml (45.0) (P less than 0.001) for FEV1, and -26.0 (72.2) ml (P less than 0.05) for FVC. In the majority of patients that died or underwent transplantation, FEV1 at the time of the last admission did not rise above 800 ml despite full treatment.

Entities:  

Mesh:

Year:  1992        PMID: 1565817     DOI: 10.1016/s0954-6111(06)80147-2

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

Review 1.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

2.  Lung function decline from adolescence to young adulthood in cystic fibrosis.

Authors:  Stacy L Vandenbranden; Ann McMullen; Michael S Schechter; David J Pasta; Rory L Michaelis; Michael W Konstan; Jeffrey S Wagener; Wayne J Morgan; Susanna A McColley
Journal:  Pediatr Pulmonol       Date:  2011-08-24

Review 3.  Exercise and cystic fibrosis.

Authors:  A K Webb; M E Dodd; J Moorcroft
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

4.  Anti-Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosis.

Authors:  E Caballero; M E Drobnic; M T Pérez; J M Manresa; A Ferrer; R Orriols
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

5.  Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis.

Authors:  J Thornton; R Elliott; M P Tully; M Dodd; A K Webb
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

6.  Relations between depressive and anxious symptoms and quality of life in caregivers of children with cystic fibrosis.

Authors:  Kimberly A Driscoll; Karen Montag-Leifling; James D Acton; Avani C Modi
Journal:  Pediatr Pulmonol       Date:  2009-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.